[Form 4] Genelux Corporation Insider Trading Activity

Rhea-AI Filing Summary

Genelux Corporation insider report: Thomas Zindrick, the company's President and CEO and a director, received equity awards that increase his potential ownership. He was granted 361,200 restricted stock units (RSUs) that convert to common shares upon vesting and a stock option covering 478,800 shares with an exercise price of $3.64. After the reported transactions, he beneficially owns 554,161 shares of common stock (including 1,514 shares from the Employee Stock Purchase Plan) and holds options exercisable into 478,800 shares. The RSUs vest 25% after one year, then quarterly over the remainder; the option vests 25% after one year, then monthly over the remainder, and expires in 2035.

Positive

• Significant equity grants to the CEO (361,200 RSUs and 478,800 options) increase management ownership alignment with shareholders
• Clear vesting schedules are provided: RSUs vest 25% after one year then quarterly; options vest 25% after one year then monthly
• Post-transaction ownership disclosed: 554,161 common shares beneficially owned, including 1,514 ESPP shares

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Executive equity grants align CEO incentives with shareholder value but warrant disclosure review for governance transparency.

The filing shows standard incentive-based compensation through RSUs and long-dated options for the President and CEO. The disclosed vesting schedules (initial 25% cliff then periodic vesting) are typical mechanisms to promote retention. The report clearly itemizes post-transaction beneficial ownership and discloses participation in the Employee Stock Purchase Plan. From a governance perspective, the important facts are transparency of grant size, vesting cadence, and exercise price; these are all provided in the filing.

Securities Analyst

TL;DR: Material equity awards materially increase the CEO's potential stake; details allow modeling of dilution and incentive alignment.

The filing documents grants totaling 361,200 RSUs and options for 478,800 shares with a $3.64 strike. Post-transaction beneficial ownership is 554,161 common shares plus 478,800 option shares outstanding to the reporting person. Vesting timelines permit forecasting when shares may enter circulation. These concrete figures enable an analyst to quantify future dilution and to model the timing of potential share issuance tied to vesting events.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zindrick Thomas

(Last) (First) (Middle)

C/O GENELUX CORPORATION

2625 TOWNSGATE ROAD, SUITE 230

(Street)

WESTLAKE VILLAGE CA 91361

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
GENELUX Corp [ GNLX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
08/27/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/27/2025		A(1)		361,200	A	$0	554,161(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$3.64	08/27/2025		A		478,800		(3)	08/26/2035	Common stock	478,800	$0	478,800	D

Explanation of Responses:

1. Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 12 equal quarterly (every 3 months) installments thereafter.

2. Includes 1514 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan.

3. The shares subject to the option will vest 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 36 equal monthly installments thereafter.

	/s/ Thomas Zindrick	08/29/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity did Genelux CEO Thomas Zindrick receive in the Form 4 (GNLX)?

He was granted 361,200 RSUs and a stock option for 478,800 shares with an exercise price of $3.64.

How many shares does Thomas Zindrick beneficially own after the reported transactions?

He beneficially owns 554,161 shares of common stock following the reported transactions.

Are there any shares from an Employee Stock Purchase Plan included?

Yes, the beneficial ownership total includes 1,514 shares acquired under the issuer's Employee Stock Purchase Plan.

What are the vesting terms for the RSUs and options granted to Thomas Zindrick?

RSUs vest 25% on the first anniversary then the remainder in 12 equal quarterly installments; the option vests 25% on the first anniversary then the remainder in 36 equal monthly installments.

What is the expiration timeline for the granted option?

The stock option is exercisable through an expiration date in 2035 as disclosed in the filing.